Younger postmenopausal patients with early-stage breast cancer may be able to safely omit adjuvant radiotherapy
Almost all postmenopausal patients aged 50-–69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years ...
Dec 7, 2023
0
0
